Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Glutathione S-Transferase Polymorphism in Iranian Patients With Type 2 Diabetic Microangiopathy Publisher



Hashemisoteh MB1 ; Ahmadzadeh Amiri A2 ; Sheikh Rezaee MR3 ; Ahmadzadeh Amiri A2 ; Ahrari R4 ; Ahmadzadeh Amiri A2 ; Daneshvar F6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Molecular and Cell Biology Research Center, Mazandaran University of Medical Science, Sari, Iran
  2. 2. Department of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Ophthalmology, Bu-Ali Sina Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4. Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
  5. 5. Diabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran
  6. 6. Department of Public Health, Mazandaran University of Medical Sciences, Sari, Iran

Source: Egyptian Journal of Medical Human Genetics Published:2020


Abstract

Background: Overproduction of reactive oxygen species as a result of hyperglycemia in diabetes mellitus leads to microvascular complications. Glutathione S-transferases play important detoxifying roles with antioxidant potentials. This study aimed to assess whether the glutathione S-transferase M1 and T1 genotypes were associated with type 2 diabetes mellitus microangiopathic complications in the Iranian population. Results: In this case-control study, the frequencies of null GSTM1 and GSTT1 genotypes were 4/72 (5.56%) and 12/72 (16.67%) respectively, in uncomplicated DM group. The frequencies of null GSTM1 and GSTT1 genotype in complicated DM group were 16/134 (11.94%) and 37/134 (27.61%), respectively. The proportion of GSTM1 null genotypes was higher in diabetic nephropathy compared to non-nephropathy (19.3% vs. 6.04 %, P = 0.006). At GSTT1 locus, patients with diabetic peripheral neuropathy had a higher frequency of deletion compared to those of without neuropathy (30.39% vs. 23.49%) (P = 0.02). Conclusion: Selective polymorphisms encoding GSTM1 and GSTT1genes may prove useful as genetic markers to recognize individuals with an increased trend in developing diabetic nephropathy and neuropathy, respectively. This will help better identify individuals at higher risk toward microvascular complications of type 2 diabetes due to genetic susceptibility. © 2020, The Author(s).
Related Docs
1. Aldose Reductase C-106T Gene Polymorphism in Type 2 Diabetics With Microangiopathy in Iranian Individuals, Indian Journal of Endocrinology and Metabolism (2015)
2. Aldose Reductase (Ac)N Gene Polymorphism in Iranian Patients With Type 2 Diabetic Microangiopathy; a Case–Control Study, Diabetology International (2021)